Orna Therapeutics

About:

Orna Therapeutics is a biotechnology company that specializes in fully engineered circular RNA therapeutics to treat various diseases.

Website: http://ornatx.com

Twitter/X: orna_tx

Top Investors: Bristol-Myers Squibb, Kite Pharma, Merck, MPM Capital, The Pags Group

Description:

Orna Therapeutics is a biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA (oRNA) therapeutics with the potential to change the way they treat disease. The company's proprietary platform combines novel technology to create oRNAs that drive protein expression with validated and unique delivery solutions. Orna Therapeutics was established in 2019 by Alex Wesselhoeft and Raffaella Squilloni in Cambridge, Massachusetts.

Total Funding Amount:

$321M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2019-01-01

Contact Email:

info(AT)ornatx.com

Hub Tags:

Unicorn

Founders:

Alex Wesselhoeft, Daniel Anderson, Raffaella Squilloni

Number of Employees:

101-250

Last Funding Date:

2022-08-16

IPO Status:

Private

© 2025 bioDAO.ai